Viral infections and human cancers: The legacy of Denis Burkitt

British Journal of Haematology

Volumn 156, Issue 6, 2012, Pages 709-718

  Harford, Joe B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Africa; Burkitt lymphoma; Human cancers; Viral infections

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS VACCINE; WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY TITER; BURKITT LYMPHOMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CAUSAL ATTRIBUTION; DNA VIRUS; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; HEPATITIS VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; KAPOSI SARCOMA; LIVER CANCER; LIVER CELL CARCINOMA; NEOPLASM; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS ISOLATION; WART VIRUS;

BURKITT LYMPHOMA; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEPATITIS; HIV INFECTIONS; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRUS DISEASES;

EID: 84857782738     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.09017.x     Document Type: Review

References (104)

1. American Cancer Society (2011) Global Cancer Facts and Figures, 2nd edn. American Cancer Society, Atlanta, GA.
2. Anonymous (2011) Battles in the war on cancer: pioneering prevention. Cancer Discovery, 1, 278.
3. Blumberg, B.S. (2002) The discovery of the hepatitis B virus and the invention of the vaccine: a scientific memoir. Journal of Gastroenterology and Hepatology, 17, S502-S503.
4. Blumberg, B.S., Gerstley, B.J., Hungerford, D.A., London, W.T. & Sutnick, A.I. (1967) A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Annals of Internal Medicine, 66, 924-931.
5. Boccardo, E. & Villa, L.L. (2007) Viral origins of human cancer. Current Medicinal Chemistry, 14, 2526-2539.
6. Boshart, M., Gissmann, L., Ikenberg, H., Kleinheinz, A., Scheurlen, W. & zur Hausen, H. (1984) A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO Journal, 3, 1151-11577.
7. Brady, G., Macarthur, G.J. & Farrell, P.J. (2008) Epstein-Barr virus and BL. Postgraduate Medical Journal, 84, 372-377.
8. Bray, F., Loos, A.H., McCarron, P., Weiderpass, E., Arbyn, M., Møller, H., Hakama, M. & Parkin, D.M. (2005) Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiology, Biomarkers and Prevention, 14, 677-686.
9. Burgos, J.S. (2005) Involvement of the Epstein-Barr Virus in the nasopharyngeal carcinoma pathogenesis. Medical Oncology, 22, 113-121.
10. Burkitt, D. (1958) A sarcoma involving the jaws in African children. British Journal of Surgery, 46, 218-223.
11. Burkitt, D.P. (1961) Observations on the geography of malignant lymphoma. East African Medical Journal, 38, 511-514.
12. Burkitt, D. (1962) A children's cancer dependent on climatic factors. Nature, 194, 232-234.
13. Burkitt, D.P. (1969a) Etiology of Burkitt's lymphoma - an alternative hypothesis to a vectored virus. Journal of the National Cancer Institute, 42, 19-28.
14. Burkitt, D.P. (1969b) A study of cancer patterns in Africa. The Scientific Basis of Medicine Annual Reviews, 1969, 82-94.
15. Burkitt, D.P. (1977) Relationships between diseases and their etiological significance. American Journal of Clinical Nutrition, 30, 262-267.
16. Burkitt, D.P. (1985) The beginnings of the Burkitt's lymphoma story. IARC Scientific Publications, 60, 11-15.
17. Burkitt, D.P. & Tunstall, M. (1975) Common geography as a clue to causation. Tropical and Geographical Medicine, 27, 117-124.
18. Burnett-Hartman, A.N., Newcomb, P.A. & Potter, J.D. (2008) Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiology, Biomarkers and Prevention, 17, 2970-2979.
19. Carrillo-Infante, C., Abbadessa, G., Bagella, L. & Giordano, A. (2007) Viral infections as a cause of cancer (review). International Journal of Oncology, 30, 1521-1528.
20. Casper, C. (2011) The increasing burden of HIV-associated malignancies in resource-limited regions. Annual Review of Medicine, 62, 157-170.
21. Chang, M.H., Chen, C.J., Lai, M.S., Hsu, H.M., Wu, T.C., Kong, M.S., Liang, D.C., Shau, W.Y. & Chen, D.S. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. New England Journal of Medicine, 336, 1855-1859.
22. Chang, M.H., You, S.L., Chen, C.J., Liu, C.J., Lee, C.M., Lin, S.M., Chu, H.C., Wu, T.C., Yang, S.S., Kuo, H.S., Chen, D.S. & Taiwan Hepatoma Study Group (2009) Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. Journal of the National Cancer Institute, 101, 1348-1355.
23. Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W. & Houghton, M. (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244, 359-362.
24. Clifford, G.M., Polesel, J., Rickenbach, M., Dal Maso, L., Keiser, O., Kofler, A., Rapiti, E., Levi, F., Jundt, G., Fisch, T., Bordoni, A., De Weck, D., Franceschi, S. & Swiss HIV Cohort. (2005) Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute, 97, 425-432.
25. Coakley, D. (2007) Irish Masters of Medicine. TownHouse, Dublin, Ireland.
26. Cook-Mozaffari, P., Newton, R., Beral, V. & Burkitt, D.P. (1998) The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. British Journal of Cancer, 78, 1521-1528.
27. Danaei, G., Vander Hoorn, S., Lopez, A.D., Murray, C.J., Ezzati, M. & Comparative Risk Assessment collaborating group (Cancers). (2005) Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet, 366, 1784-1793.
28. Dane, D., Cameron, C.H. & Briggs, M. (1970) Virus-Like Particles in Serum of Patients with Australia-Antigen-Associated Hepatitis. The Lancet, 295, 695-698.
29. Dienstag, J.L., Purcell, H.R., Alter, H.J., Feinstone, S.M., Wong, D.C. & Holland, P.V. (1977) Non-A, non-B post transfusion hepatitis. Lancet, 1, 560-562.
30. Dürst, M., Gissmann, L., Ikenberg, H. & zur Hausen, H. (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proceedings of the National Academy of Sciences of the United States of America, 80, 3812-3815.
31. Engels, E.A., Frisch, M., Lubin, J.H., Gail, M.H., Biggar, R.J. & Goedert, J.J. (2002) Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. Journal of Acquired Immune Deficiency Syndromes, 31, 536-541.
32. Engels, E.A., Biggar, R.J., Hall, H.I., Cross, H., Crutchfield, A., Finch, J.L., Grigg, R., Hylton, T., Pawlish, K.S., McNeel, T.S. & Goedert, J.J. (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. International Journal of Cancer, 123, 187-194.
33. Epstein, M.A. (2001) Historical perspective. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 356, 413-420.
34. Epstein, M.A., Achong, B.G. & Barr, Y.M. (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet, 1, 702-703.
35. Feng, H., Shuda, M., Chang, Y. & Moore, P.S. (2008) Clonal integration of a polyomavirus in human merkel cell carcinoma. Science, 319, 1096-1100.
36. Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C. & Parkin, D.M. (2010) GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France. Available from:.
37. Frazer, I.H. (2010) Cervical cancer vaccine development. Sexual Health, 7, 230-234.
38. Frisch, M., Biggar, R.J. & Goedert, J.J. (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Journal of the National Cancer Institute, 92, 1500-1510.
39. Frisch, M., Biggar, R.J., Engels, E.A. & Goedert, J.J. (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA, 2001, 285.
40. Goedert, J.J. (2000) The epidemiology of acquired immunodeficiency syndrome malignancies. Seminars in Oncology, 27, 390-401.
41. Goedert, J.J., Cote, T.R., Virgo, P., Scoppa, S.M., Kingma, D.W., Gail, M.H., Jaffe, E.S. & Biggar, R.J. (1998) Spectrum of AIDS-associated malignant disorders. Lancet, 351, 1833-1839.
42. Greaves, M. (2006) Infection, immune responses and the aetiology of childhood leukaemia. Nature Reviews Cancer, 6, 193-203.
43. Gross, L. (1951) "Spontaneous" leukemia developing in C3H mice following inoculation in infancy with AK leukemia extracts, causing salivary gland carcinoma in C3H mice. Proceedings of the Society for Experimental Biology and Medicine, 83, 414-421.
44. Grulich, A.E., van Leeuwen, M.T., Falster, M.O. & Vajdic, C.M. (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet, 370, 59-67.
45. Harper, D.M., Franco, E.L., Wheeler, C., Ferris, D.G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N.S., Roteli-Martins, C.M., Teixeira, J., Blatter, M.M., Korn, A.P., Quint, W., Dubin, G. & GlaxoSmithKline HPV Vaccine Study Group. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet, 364, 1757-1765.
46. zur Hausen, H. (1996) Papillomavirus infections-a major cause of human cancers. Biochim et Biophysica Acta, 1288, F55-F78.
47. zur Hausen, H. (1999) Viruses in human cancers. European Journal of Cancer, 35, 1878-1885.
48. zur Hausen, H. (2008) Novel human polyomaviruses-re-emergence of a well known virus family as possible human carcinogens. International Journal of Cancer, 123, 247-250.
49. zur Hausen, H. (2009a) Papillomaviruses in causation of human cancers-a brief historical account. Virology, 384, 260-265.
50. zur Hausen, H. (2009b) The search for infectious causes of human cancers: where and why (Nobel lecture). Angewandte Chemie (International ed. in English), 48, 5798-5808.
51. zur Hausen, H. (2009c) Childhood leukemias and other hematopoietic malignancies: interdependence between and infectious event and chromosomal modifications. International Journal of Cancer, 125, 1764-1770.
52. Henle, W. & Henle, G. (1974) The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma. Annals of Clinical and Laboratory Science, 4, 109-114.
53. Houghton, M. (2009) The long and winding road leading to the identification of the hepatitis C virus. Journal of Hepatology, 51, 939-948.
54. Hutt, M.S. & Burkitt, D. (1965) Geographical distribution of cancer in East Africa: a new clinicopathological approach. British Medical Journal, 2, 719-722.
55. IARC (2005) Cervix Cancer Screening, IARC Handbooks on Cancer Prevention, Vol. 10. IARC Press, Lyon, France.
56. Ikenberg, H., Gissmann, L., Gross, G., Grussendorf-Conen, E.I. & zur Hausen, H. (1983) Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. International Journal of Cancer, 32, 563-565.
57. Jeang, K.T. (2010) HTLV-1 and adult T-cell leukemia: insights into viral transformation of cells 30years after virus discovery. Journal of the Formosan Medical Association, 109, 688-693.
58. Kirk, G.D., Merlo, C., O'Driscoll, P., Mehta, S.H., Galai, N., Vlahov, D., Samet, J. & Engels, E.A. (2007) HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clinical Infectious Diseases, 45, 103-110.
59. Kiyosawa, K., Tanaka, E., Sodeyama, T., Furuta, K., Usuda, S., Yousuf, M. & Furuta, S. (1990) Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma. Japanese Journal of Cancer Research, 81, 1089-1091.
60. Lam, K.M., Syed, N., Whittle, H. & Crawford, D.H. (1991) Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet, 337, 876-878.
61. Liebowitz, D. (1994) Nasopharyngeal carcinoma: the Epstein-Barr virus association. Seminars in Oncology, 21, 376-381.
62. Lu, B., Kumar, A., Castellsagué, X. & Giuliano, A.R. (2011) Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infectious Diseases, 11, 3.
63. Lucké, B. (1938) Carcinoma in the leopard frog: its probable causation by a virus. The Journal of Experimental Medicine, 68, 457-468.
64. Lydon, P., Beyai, P.L., Chaudhri, I., Cakmak, N., Satoulou, A. & Dumolard, L. (2008) Government financing for health and specific national budget lines: the case of vaccines and immunization. Vaccine, 26, 6727-6734.
65. Mackay, J., Jemal, A., Lee, N.C. & Parkin, D.M. (2006) The Cancer Atlas. American Cancer Society, Altlanta, GA.
66. Martin, D. & Gutkind, J.S. (2009) Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene, 27, S31-S42.
67. Mbulaiteye, S.M., Talisuna, A.O., Ogwang, M.D., McKenzie, F.E., Ziegler, J.L. & Parkin, D.M. (2010) African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate?Lancet, 375, 1661-1663.
68. McCormack, P.L. & Joura, E.A. (2010) Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women. Drugs, 70, 2449-2474.
69. Moormann, A.M., Chelimo, K., Sumba, O.P., Lutzke, M.L., Ploutz-Snyder, R., Newton, D., Kazura, J. & Rochford, R. (2005) Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. Journal of Infectious Diseases, 191, 1233-1238.
70. Muñoz, N., Bosch, F.X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K.V., Snijders, P.J. & Meijer, C.J. (2003) International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine, 348, 518-527.
71. Nguyen, M.L., Farrell, K.J. & Gunthel, C.J. (2010) Non-AIDS- defining malignancies in patients with HIV in the HAART era. Current Infectious Disease Reports, 12, 46-55.
72. Ott, J.J., Ulrich, A., Mascarenhas, M. & Stevens, G.A. (2010) Global cancer incidence and mortality caused by behavior and infection. Journal of Public Health, 33, 223-233.
73. Padian, N.S., McCoy, S.I., Karim, S.S., Hasen, N., Kim, J., Bartos, M., Katabira, E., Bertozzi, S.M., Schwartländer, B. & Cohen, M.S. (2011) HIV prevention transformed: the new prevention research agenda. Lancet, 378, 269-278.
74. Parkin, D.M. (2006) The global health burden of infecion-associated cancers in the year 2002. International Journal of Cancer, 118, 3030-3044.
75. Parkin, D.M. & Bray, F. (2006) The burden of HPV-related cancers. Vaccine, 24, S11-S25.
76. Perz, J.F., Armstrong, G.L., Farrington, L.A., Hutin, Y.J. & Bell, B.P. (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology, 45, 529-538.
77. Popovic, M., Reitz, Jr, M.S., Sarngadharan, M.G., Robert-Guroff, M., Kalyanaraman, V.S., Nakao, Y., Miyoshi, I., Minowada, J., Yoshida, M., Ito, Y. & Gallo, R.C. (1982) The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature, 300, 63-66.
78. Raab-Traub, N. (2002) Epstein-Barr virus in the pathogenesis of NPC. Seminars in Cancer Biology, 12, 431-441.
79. Raza, S.A., Clifford, G.M. & Franceschi, S. (2007) Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. British Journal of Cancer, 96, 1127-1134.
80. Rous, P. (1911) A sarcoma of the fowl transmissible by an agent separable from the tumor cells. The Journal of Experimental Medicine, 13, 397-411.
81. Saha, A., Kaul, R., Murakami, M. & Robertson, E.S. (2010) Tumor viruses and cancer biology: modulating signaling pathways for therapeutic intervention. Cancer Biology & Therapy, 10, 961-978.
82. Samaras, V., Rafailidis, P.I., Mourtzoukou, E.G., Peppas, G. & Falagas, M.E. (2010) Chronic bacterial and parasitic infections and cancer: a review. Journal of Infection in Developing Countries, 3, 267-281.
83. Schiffman, M. & Castle, P.E. (2005) The promise of global cervical-cancer prevention. New England Journal of Medicine, 353, 2101-2104.
84. Schiller, J.T. & Lowy, D.R. (2010) Vaccines to prevent infections by oncoviruses. Annual Review of Microbiology, 64, 23-41.
85. Serraino, D., Pezzotti, P., Dorrucci, M., Alliegro, M.B., Sinicco, A. & Rezza, G. (1997) Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer, 79, 1004-1008.
86. Shiels, M.S., Pfeiffer, R.M., Gail, M.H., Hall, I., Li, J., Chaturvedi, A.K., Bhatia, K., Uldick, T.S., Yarchoan, R., Goedert, J.J. & Engels, E.A. (2011) Cancer burden in the HIV-infected population in the United States. Journal of the National Cancer Institute, 1-3, 753-762.
87. Simbiri, K.O., Murakami, M., Feldman, M., Steenhoff, A.P., Nkomazana, G.B. & Robertson, E.S. (2010) Multiple oncogenic viruses identified in ocular surface squamous neoplasia in HIV-1 patients. Infectious Agents and Cancer, 5, 6.
88. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M.F., Clauvel, J.P., Raphael, M., Degos, L. & FranGois Sigaux (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood, 86, 1276-1280.
89. Sripa, B., Kaewkes, S., Sithithaworn, P., Mairiang, E., Laha, T., Smout, M., Pairojkul, C., Bhudhisawasdi, V., Tesana, S., Thinkamrop, B., Bethony, J.M., Loukas, A. & Brindley, P.J. (2007) Liver fluke induces cholangiocarcinoma. PLoS Medicine, 4, e201. PMID: 17622191.
90. de-Thé, G., Geser, A., Day, N.E., Tukei, P.M., Williams, E.H., Beri, D.P., Smith, P.G., Dean, A.G., Bronkamm, G.W., Feorino, P. & Henle, W. (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature, 274, 756-761.
91. Thun, M.J., DeLancey, J.O., Center, M.M., Jemal, A. & Ward, E.M. (2010) The global burden of cancer: priorities for prevention. Carcinogenesis, 31, 100-110.
92. UN Joint Programme on HIV/AIDS (2010) Global Report: UNAIDS Report on the Global AIDS Epidemic: 2010. UN Joint Programme on HIV/AIDS, Geneva, Switzerland. ISBN 978-92-9173-871-7 (NLM classifi cation: WC 503.4).
93. Venook, A.P., Papandreou, C., Furuse, J. & de Guevara, L.L. (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist, 15(Suppl. 4), 5-13.
94. Vidrine, D.J. (2009) Cigarette smoking and HIV/AIDS: health implications, smoker characteristics and cessation strategies. AIDS Education and Prevention, 21(Suppl. 3), 3-13.
95. Villa, L.L., Costa, R.L., Petta, C.A., Andrade, R.P., Paavonen, J., Iversen, O.E., Olsson, S.E., Høye, J., Steinwall, M., Riis-Johannessen, G., Andersson-Ellstrom, A., Elfgren, K., Krogh, G., Lehtinen, M., Malm, C., Tamms, G.M., Giacoletti, K., Lupinacci, L., Railkar, R., Taddeo, F.J., Bryan, J., Esser, M.T., Sings, H.L., Saah, A.J. & Barr, E. (2006) High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18L1 virus-like particle vaccine through 5years of follow-up. British Journal of Cancer, 95, 1459-1466.
96. Vousden, K.H. & Farrell, P.J. (1994) Viruses and human cancer. British Medical Bulletin, 50, 560-581.
97. Wabinga, H.R., Parkin, D.M., Wabwire-Mangen, F. & Mugerwa, J.W. (1993) Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. International Journal of Cancer, 22, 26-36.
98. Whittle, H.C., Maine, N., Pilkington, J., Mendy, M., Fortuin, M., Bunn, J., Allison, L., Howard, C. & Hall, A. (1995) Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet, 345, 1089-1092.
99. WHO (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, 61, 45-119.
100. WHO (2008a) The Global Burden of Disease: 2004 Update. World Health Organization, Geneva, Switzerland.
101. WHO (2008b) Hepatitis B. Factsheet No 204. World Health Organization, Geneva, Switzerland.
102. WHO (2011) Hepatitis C. Factsheet No 164. World Health Organization, Geneva, Switzerland.
103. Wild, C.P. & Montesano, R. (2009) A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. Cancer Letters, 286, 22-28.
104. Ziegler, J.L. & Buonaguro, F.M. (2009) Infectious agents and human malignancies. Frontiers in Bioscience, 14, 3455-3464.